MedPath

The effect of the combination of Lavandula angustifolia and Dracocephalum ruyschiana on mild to moderate depressio

Phase 3
Conditions
Major Depression.
Major depressive disorder, single episode, unspecified
F32.9
Registration Number
IRCT20200427047216N2
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

the onset of disease in the last 6 months
diagnosis of major depression with mild to moderate level.

Exclusion Criteria

neurological and physical disorders, mental disorders other than generalized anxiety disorder
using medication in the past month

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression. Timepoint: Evaluation of the rate of depression with a back test (BDI) at the beginning of the study and 60 days after taking the syrup containing the extracts. Method of measurement: The Beck Depression Inventory (BDI) questionnaire was used for evaluation of the effects of the intervention. This scale is one of the most valid diagnostic tools for depression whose validity and reliability have been confirmed in various studies.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath